Views & Analysis Non-profit model for childhood cancer drugs Charities must work to help pharma and academia prioritise and accelerate paediatric treatments.
News Government wasted £1.3 billion on Cancer Drugs Fund, says st... The £1.3 billion of public expenditure on the old Cancer Drugs Fund (CDF) did not deliver value to patients or society, according to a new study.
News AstraZeneca's Cambridge R&D site build running years late Building not operational until 2019, says CEO
Views & Analysis Take a breath - this could be the definitive cancer screenin... Can breath be the basis for the ultimate cancer screening tool?
News FDA approves new uses for two Roche drugs FDA hands out new indications for Tecentriq and Lucentis.
News UK and US spearhead search for drugs targeting RAS mutations Cancer Research UK and its Cancer Research Technology Pioneer Fund have joined with the US National Cancer Institute (NCI) to test new molecules targeting RAS mutations.
News Diagnostics lag is holding back new therapies, says study Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
